TiumBio Co. Ltd
TiumBio Co., Ltd., a drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases. The company's products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, and NBP604. It has a collaboration agreement with Oncodesign Société Anonyme for the research and development of fibrosis drug candidates. The co… Read more
TiumBio Co. Ltd (321550) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.130x
Based on the latest financial reports, TiumBio Co. Ltd (321550) has a cash flow conversion efficiency ratio of -0.130x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.68 Billion) by net assets (₩35.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TiumBio Co. Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how TiumBio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TiumBio Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TiumBio Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
National Fertilizers Limited
NSE:NFL
|
-0.903x |
|
China Boton Group Company Limited
PINK:CHBGF
|
N/A |
|
Cibus Global LLC
NASDAQ:CBUS
|
-0.226x |
|
JS Corp
KO:194370
|
0.099x |
|
SPEEDY HIRE LS-05
F:5HN
|
N/A |
|
Thejo Engineering Limited
NSE:THEJO
|
0.082x |
|
Camuzzi Gas Pampeana SA
BA:CGPA2
|
0.346x |
|
Hua Eng Wire & Cable Co Ltd
TW:1608
|
0.026x |
Annual Cash Flow Conversion Efficiency for TiumBio Co. Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of TiumBio Co. Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩52.47 Billion | ₩-15.63 Billion | -0.298x | -1.67% |
| 2023-12-31 | ₩70.37 Billion | ₩-20.62 Billion | -0.293x | -11.67% |
| 2022-12-31 | ₩61.04 Billion | ₩-16.01 Billion | -0.262x | +7.37% |
| 2021-12-31 | ₩87.57 Billion | ₩-24.80 Billion | -0.283x | -149.14% |
| 2020-12-31 | ₩82.51 Billion | ₩-9.38 Billion | -0.114x | -136.26% |
| 2019-12-31 | ₩92.50 Billion | ₩-4.45 Billion | -0.048x | +72.61% |
| 2018-12-31 | ₩28.75 Billion | ₩-5.05 Billion | -0.176x | -134.47% |
| 2017-12-31 | ₩-7.09 Billion | ₩-3.61 Billion | 0.510x | -- |